Tirzepatide added years to my life and I’m more confident than ever. After officially hitting my goal weight, it took a month to completely wean off the medication by August 2023.

The US Food and Drug Administration (FDA) has stood by an earlier decision confirming that the tirzepatide shortage is over. The end of the shortage means that pharmacies making compounded ...

Before the development of tirzepatide and similar obesity drugs, lifestyle modifications were the main way to treat obesity, Krumholz said. Though these are also beneficial, a healthy diet and ...

Tirzepatide, a medication authorised to treat obesity and/or type 2 diabetes, consistently reduces bodyweight regardless of the patient’s body mass index (BMI before treatment), from the range ...

Tirzepatide stimulates the pancreas to release insulin in response to meals. This action helps lower blood sugar levels after eating, which is crucial for managing diabetes. Reducing Glucagon Release ...

The FDA decided the shortage for Eli Lilly's GLP-1 tirzepatide has finally come to an end. ... Eli Lilly's stock rose 9% in premarket trading before the bell on Friday.